Skip to main content
Atrys Health S.A. logo

Atrys Health S.A. — Investor Relations & Filings

Ticker · ATRY ISIN · ES0105148003 LEI · 959800HHEE9W4TZA8627 BME Growth Human health and social work activities
Open in API
Filings indexed 190 across all filing types
Latest filing 2026-05-21 Investor Presentation
Country ES Spain
Listing BME Growth ATRY

About Atrys Health S.A.

https://www.atryshealth.com/en/

Atrys Health is a biomedical company focused on preventive and precision medicine. It provides advanced diagnostic services and medical treatments, with a primary specialization in oncology. The company develops predictive and personalized cancer therapies and is a leader in telemedicine, offering telediagnosis and teleradiology services. Atrys Health also utilizes last-generation and personalized radiotherapy techniques for cancer treatment. It creates innovative healthcare solutions for a diverse client base, including individual patients, healthcare professionals, medical facilities, and other companies within the healthcare sector.

Recent filings

Filing Released Lang Actions
Atrys remite la presentación de resultados relativos al Q1 2026
Investor Presentation Classification · 98% confidence The document is titled “Presentación Resultados financieros 1Q 2026” and is structured as a slide‐style deck with highlights, charts/images, financial summaries, segment breakdowns, guidance, and annexes. It reads as an investor/investment analyst presentation rather than a formal statutory interim report or earnings release. Therefore, it falls under the Investor Presentation category (IP).
2026-05-21 Spanish
Atrys Health remite la nota de prensa sobre los resultados Q1 2026
Earnings Release Classification · 90% confidence The document is a press release dated 21 May 2026 detailing the company’s first-quarter 2026 financial performance with key highlights: revenue growth, EBITDA improvement, cash flow, net debt reduction, and guidance. It does not include full financial statements or serve as a formal interim report but rather an earnings announcement summarizing period results. Therefore, it is classified as an Earnings Release (ER). Q1 2026
2026-05-21 Spanish
Atrys Health remite la presentación de resultados del Q1 2026
Earnings Release Classification · 92% confidence The document is a press release announcing Atrys Health’s first-quarter 2026 financial results, with high-level figures on revenue, EBITDA, cash flow, net debt reduction, and guidance—typical of an initial quarterly earnings announcement. It does not present the full interim financial statements or detailed management discussion as an Interim Report, but instead summarizes key metrics, fitting the definition of an Earnings Release (ER). Q1 2026
2026-05-21 Spanish
Atrys comunica las operaciones de liquidez del periodo 1 de febrero de 2026 al 30 de abril de 2026
Transaction in Own Shares Classification · 92% confidence The document is a CNMV “Información Relevante” disclosure of operations under a liquidity contract (“Contrato de Liquidez”) for Atrys Health, S.A., detailing purchases and sales of the company’s own shares during the period. This matches the definition of a Transaction in Own Shares (share repurchase/sale) under category POS.
2026-05-19 Spanish
Atrys publica la convocatoria de Junta General Ordinaria el 18 de junio de 2026
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a formal convocation notice for the Annual General Meeting (Junta General Ordinaria de Accionistas) of Atrys Health, S.A., published under EU MAR article 17. It lays out the agenda, proposals, information and documentation available to shareholders, and explains voting and proxy procedures in detail. This corresponds to “materials sent to shareholders to provide information and request votes for meetings,” matching the Proxy Solicitation & Information Statement category.
2026-05-14 Spanish
Atrys publica la convocatoria de Junta General Ordinaria el 18 de junio de 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal convocation (notice) of the Annual General Meeting (“Junta General Ordinaria de Accionistas”) with the agenda, shareholder information rights, proxy and voting procedures, and details on how to access the meeting materials. It is not the meeting minutes or results, nor an earnings announcement or financial report. These characteristics align with a Proxy Solicitation & Information Statement, which provides shareholders with meeting details and solicits votes. Therefore, the correct classification is PSI.
2026-05-14 Spanish

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.